Sodium Fluoride F-18

Tier C — Watch / trade

Advanced Accelerator Applications Sa

Originator

2008

First approval

Expiry (public)

No sales data

Peak sales

Small molecule

Type

Targets：Not applicable

Brand：IASOflu

Indications (approved)：Bone metastases, Contrast imaging

Regional status

Phase I

2010-03-01

Approved

2008-01-01

China

Approved

2024-09-03

Japan

Factories producing this API4

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

4 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Sodium Fluoride F-18?

Approved indications include: Bone metastases, Contrast imaging.

When does the Sodium Fluoride F-18 patent expire?

No public expiry year is available for Sodium Fluoride F-18 yet; this page updates once verified.

How do I get a quote for Sodium Fluoride F-18 intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29